Friday, 22 Jun 2018

You are here

Oral Anticoagulation Effective Following Hip and Knee Replacement Surgery

Many protocols call for anticoagulation after total hip or total knee arthroplasty to prevent venous thromboembolism (proximal deep-vein thrombosis or pulmonary embolism), and some reports have suggested a role for aspiring or direct oral anticoagulants as preventative therapy.

Patients undergoing total hip or knee arthroplasty were given oral rivaroxaban (Xarelto) 10 mg until postoperative day 5 and then were randomly assigned to continue rivaroxaban (RIX) or switch to aspirin (81 mg daily) for an additional 9 days after total knee arthroplasty (TKA) or for 30 days after total hip arthroplasty (THA). The primary outcome was venous thromboembolism by 90 days. 

They enrolled 3424 patients (1804 THA and 1620 TKA) were enrolled in the trial. There was no difference in the frequency of venous thromboembolism in the ASA patients (0.64%) and RIX patients (0.70%).

There was no significant difference in major bleeding complications with ASA (0.47%) or RIX (0.29%) post-operatively.

These results suggest that extended prophylaxis with either ASA or RIX was equally effective after an initial 5 days course of RIX following THA or TKA, thereby demonstrating effective prevention of venous thromboembolism with oral direct anticoagulation. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.

Trump Blasts Drug Makers on the Price of Drugs

Reuter's reports Friday that President Donald Trump blasted drugmakers and healthcare “middlemen” for making prescription drugs unaffordable for Americans. Nonetheless, many healthcare stocks rose as it became clear the administration had avoided taking aggressive and direct measures to cut drug prices.

Here are many New Sources on this developing story:

Patients May Not Fill Your Prescription

A new study linking administrative claims and electronic health records (EHRs) shows that nearly 40% of patients fill and take newly prescribed methotrexate (MTX), tofacitinib or biologics. 

Kan et al set out to estimate the extent and predictors of primary nonadherence in rheumatoid arthritis (RA) patients who received new prescriptions for methotrexate, biologics or tofacitinib.